The drug’s Phase 3 results are comparable to those of Trodelvy, a TROP2-targeting ADC marketed by Gilead Sciences as a second-line treatment for HR positive, HER2 negative breast cancer ...

Visibly alarmed by the situation, Akufo-Addo paused his address briefly to ensure his ADC received urgent care before resuming his speech. The aide-de-camp of the Vice President, Mahamudu Bawumia ...

Bot Lane diversity in League of Legends has expanded to include marksmen, mages, and fighters, providing more strategic options. The best Bot Laners are subject to frequent meta shifts due to ...